Printer Friendly

The Grants and Contracts Operations Branch (GCOB) provides an administrative and managerial focal point for the support and coordination of projects for the Developmental Therapeutics Program funded by grants, contracts and cooperative agreements.

What's New!

• Development of High Throughput Drug Screening, PA 04-068, NIH Guide, 2/25/04 GCOB is representing NCI in this new initiative with the National Diabetes and Digestive and Kidney Diseases and the National Institute of Allergy and Infections Diseases.
  
• Developmental Project in Complementary Approaches to Cancer, PA 04-053, NIH Guide, 2/02/04 In this new initiative, GCOB is cooperating with the NCI Office of Cancer Complementary and Alternative Medicine, National Institute of Nursing Research, and the National Institute of Dental and Craniofacial Research.
  
• NATIONAL COOPERATIVE DRUG DISCOVERY GROUPS FOR CANCER, RFA-CA-05-001, NIH Guide, 1/16/04 (Letter of Intent Receipt Date: April 19, 2004; Application Receipt Date: May 19, 2004)
  This RFA is a reissuance of RFA-CA-99-010, which was published in the NIH Guide on April 14, 1999.

Other Program Interests:

• Academic Public Private Partnership Program (AP4) Planning Grant
• International Cooperative Biodiversity Groups (ICBG), RFA TW-03-004

• NCI Specialized Programs of Research Excellence (SPOREs)

• NIH Inter-Institute Pilot Program for the Development of AIDS-Related Therapeutics

• Rapid Access to NCI Discovery Resources (R*A*N*D) Program

• Rapid Access to Intervention Development (RAID)

• Angiogenesis Resource Center

• PHS 2004-2 SBIR/STTR Phase I Solicitation
  Receipt Dates for SBIR/STTR Grant Awards: April 1, August 1 and December 1

• Therapeutics Research on AIDS-Associated Opportunistic Infections and Malignancies

• Models for HIV Disease and AIDS-Related Malignancies

• Flexible System to Advance Innovative Research for Cancer Drug Discovery by Small Businesses (FLAIR)

• Innovative Toxicology Models for Drug Evaluation: SBIR/STTR Initiative

• Combinatorial Libraries (Samples and Services)
  

• Molecular Target Drug Discovery for Cancer
  

Related Links:

Division of Cancer Treatment and Diagnosis (New website)
NIH Support for Conferences and Scientific Meetings (R13 and U13)
NIH Support for Conferences and Scientific Meetings (PAR-03-176)
Guidelines for Inclusion of Women, Minorities, and Persons with Disabilities in NIH-Supported Conference Grants (NOT-OD-03-066)
The NCI Grants Process Book
Information for Researchers Using Human Specimens
NIH "Welcome Wagon" Letter (Information for New Grantee Organizations)
Salary Limitation on Grants, Cooperative Agreements and Contracts
Final NIH Statement on Sharing Research Data
Reminder to Applicants about Requirement to Submit Complete and Up-to-Date Other Support Information
HIPAA Privacy Rule (02/05/03)
Resubmission Policy Notice
Revised NIH Grants Policy Statement (3/01/01)
Small Business Funding Opportunities (SBIR and STTR)
Erlangen/Bethesda Data and Online Services in Chemistry
Center for Drug Evaluation and Research, FDA.
NCI ByPass Budget
NIH News Flashes
Cancer Information Service
NCI Resources
Tissue Array Resource Program
Funding Opportunities
NIH Guide
Notice on Reorganization of NIH Guide Files and Renaming of Older Folders
Office of Laboratory Animal Welfare (OLAW)
Office for Human Research Protections (OHRP)
Program Project Grants
Grant Policies
Types of Grants Defined
NCI Program Directors for Grants
Forms
Center for Scientific Review (CSR)
CSR Study Section Rosters
Contracts